Abstract Description

Drawing on extensive operational experience and proven outcomes within the sector, this talk presents a practical roadmap for achieving African Medicine Security through the localization of the cannabinoid value chain. We will move beyond the "export-only" narrative to discuss the execution of a 100% African supply chain—eliminating reliance on imported raw materials by establishing robust, local GMP infrastructure.

The discussion will cover:
- Clinical Validation & Access: Leveraging cannabinoids as low-cost generic medicines for validated therapeutic areas, directly addressing the continent’s healthcare burden. 
- Infrastructure: The technical realities of building pharmaceutical-grade facilities on African soil. 
- Community Impact: How sovereign production models can integrate traditional cultivators, ensuring that novel drug development translates into tangible economic prosperity for local communities. 

Join us for a deep dive into the realities, the data, and the future possibilities of African pharmaceutical sovereignty.